[1] |
李艳, 陈明, 金滢, 等. 高效孕激素治疗子宫内膜复杂不典型增生及子宫内膜癌的预后分析[J]. 基础医学与临床, 2017, 37:436-442.
|
[2] |
Passarello K, Kurian S, Villanueva V. Endometrial cancer: an overview of pathophysiology, management, and care[J]. Semin Oncol Nurs, 2019, 35:157-165.
|
[3] |
Yu C, Niu X, Du Y, et al. IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment[J]. Cancer Immunol Immunother, 2020, 69:115-126.
|
[4] |
Hao J, Yan F, Zhang Y, et al. Expression of adipocyte/macrophage fatty acid-binding protein in tumor-associated macrophages promotes breast cancer progression[J]. Cancer Res, 2018, 78:2343-2355.
|
[5] |
陈纪超, 吴旭. miR-203通过靶向FABP4抑制肺癌细胞的转移[J]. 南方医科大学学报, 2018, 38:578-583.
|
[6] |
Mao W, Wei S, Yang H, et al. Clinicopathological study of organ metastasis in endometrial cancer[J]. Future Oncol, 2020, 16:525-540.
|
[7] |
黄锦, 刘佳淑, 刘胜凤, 等. MicroRNA-873在子宫内膜癌中的表达及对肿瘤细胞增殖和侵袭的影响[J]. 临床检验杂志, 2020, 38:922-925.
|
[8] |
Zeng J, Sauter ER, Li B. FABP4: A new player in obesity-associated breast cancer[J]. Trends Mol Med, 2020, 26:437-440.
|
[9] |
Zhong CQ, Zhang XP, Ma N, et al. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma[J]. Cancer Med, 2018, 7:2629-2640.
|
[10] |
Zhang Y, Zhao X, Deng L, et al. High expression of FABP4 and FABP6 in patients with colorectal cancer[J]. World J Surg Oncol, 2019, 17:171-180.
|
[11] |
毛英, 黄湖南, 王建荣, 等. 脂肪酸转运蛋白-4在乳腺癌细胞转移中的作用及机制[J]. 实用医学杂志, 2018, 34:1816-1820.
|
[12] |
Tian W, Zhang W, Zhang Y, et al. FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport[J]. Cancer Cell Int, 2020, 20:512-525.
|
[13] |
Zhang Y, Zhang W, Xia M, et al. High expression of FABP4 in colorectal cancer and its clinical significance[J]. J Zhejiang Univ Sci B, 2021, 22:136-145.
|